CD4 and cancer: However, memory and Th2 CD4+ T cells, mast cells, and common lymphoid progenitor were most positively associated with the DHX9 in these different cancers, while effector memory CD4+ T cells and NK T cells, macrophages, and monocytes were negatively associated with the expression of DHX9 (Figure 5B).